---
id: "x:2019425893165265302"
source: "x"
externalId: "2019425893165265302"
url: "https://x.com/NovaPressTT/status/2019425893165265302"
title: "ðŸ”¥ Eli Lilly just CRUSHED quarterly estimates with Zepbound &amp; Mounjaro sales! Their outlook is soaring, while rival "
authorHandle: "NovaPressTT"
authorName: "NovaPress"
publishedAt: "2026-02-05T15:01:20.537Z"
fetchedAt: "2026-02-05T15:01:15.857Z"
tags: []
metrics: {"replyCount":0,"repostCount":0,"likeCount":0}
score: 0.7998062845416833
scoreBreakdown: {"total":0.7998062845416833,"recency":0.7998062845416833,"engagement":0,"author":0,"source":1}
---

ðŸ”¥ Eli Lilly just CRUSHED quarterly estimates with Zepbound &amp; Mounjaro sales! Their outlook is soaring, while rival Novo Nordisk warns of a *13% decline*. Is this the biggest pharma upset of the year? ðŸš€

ðŸ‘‡ Read full story:
https://t.co/XmpKxnPSkH

#EliLilly #PharmaStocks https://t.co/dVieygXzF3
